Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Mar/30/2021 33 6
Rapamycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 6 0
Ribavirin Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021 10 2
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Fluoxetine  Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/15/2021 4 0
Bortezomib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/12/2021 3 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/08/2021 25 7
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/08/2021 40 43
Indinavir Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/07/2021 7 1
Remdesivir Approved by FDA Experimental Antiviral Mar/05/2021 60 4